AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
105 hedge funds and large institutions have $138M invested in Accelerate Diagnostics in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 28 increasing their positions, 34 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
29% less capital invested
Capital invested by funds: $195M → $138M (-$56.4M)
79% less call options, than puts
Call options by funds: $270K | Put options by funds: $1.31M
Holders
105
Holding in Top 10
2
Calls
$270K
Puts
$1.31M
Top Buyers
| 1 | +$3.44M | |
| 2 | +$1.05M | |
| 3 | +$693K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$558K |
| 5 |
Baird Financial Group
Milwaukee,
Wisconsin
|
+$419K |
Top Sellers
| 1 | -$5.37M | |
| 2 | -$1.1M | |
| 3 | -$893K | |
| 4 |
Charles Schwab
San Francisco,
California
|
-$872K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$633K |